(Q38215807)

31 August 2017

title

Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. (English)

1 reference

chronic obstructive pulmonary disease

31 August 2017

main subject

1 reference

2

Jonathon Leipsic

1 reference

31 August 2017

Harvey O Coxson

1

1 reference

31 August 2017

Grace Parraga

series ordinal

3

1 reference

31 August 2017

Don D Sin

series ordinal

4

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

31 August 2017

published in

1 reference

31 August 2017

volume

190

1 reference

31 August 2017

issue

2

1 reference

31 August 2017

page(s)

135-144

1 reference

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

NIH disease funding levels and burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Health status and the spiral of decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Quantitative chest tomography in COPD research: chairman's summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Selection of patients for lung volume reduction surgery using a power law analysis of the computed tomographic scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Computed tomography assessment of lung volume changes after bronchial valve treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

A randomized study of endobronchial valves for advanced emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Pulmonary emphysema subtypes on computed tomography: the MESA COPD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Airflow limitation and airway dimensions in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Airway imaging in disease: gimmick or useful tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Fleischner Society: glossary of terms for thoracic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Bronchiolitis in young female smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Pulmonary arterial enlargement and acute exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

A prospective evaluation of dose reduction and image quality in chest CT using adaptive statistical iterative reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Emphysema quantification by low-dose CT: potential impact of adaptive iterative dose reduction using 3D processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Quantitative computed tomography in COPD: possibilities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Quantification of pulmonary inflammation after segmental allergen challenge using turbo-inversion recovery-magnitude magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

MRI of the lung (3/3)-current applications and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: in vivo validation with hyperpolarized 3He and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Magnetic resonance imaging with laser-polarized noble gases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Hyperpolarized (3) He and (129) Xe MRI: differences in asthma before bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Pulmonary ultrashort echo time 19F MR imaging with inhaled fluorinated gas mixtures in healthy volunteers: feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized ³He MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Hyperpolarized 3He functional magnetic resonance imaging of bronchoscopic airway bypass in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Hyperpolarized helium-3 magnetic resonance imaging of chronic obstructive pulmonary disease exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 magnetic resonance imaging: differences in COPD and relationship to emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201402-0256PP

10.1164/RCCM.201402-0256PP

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference